Bill Ackman, who outlined plans to create a modern Berkshire Hathaway earlier this year, has 39% of his portfolio split ...

One key indicator looks quite bad, but it can't get much worse. When you drive past a deserted mall's parking lot, you cannot ...

The George Soros protege has generated legendary returns for decades, so it's hard not to take stock in where Druckenmiller ...

Broadcom's ASICs are expected to help OpenAI improve speed while also being more energy efficient. This deal established ...

Since Beyond Meat stock hit a 52-week high of $7.69 on Oct. 22, the shares have cratered 89%, as of this writing. A likely ...

With CarMax currently operating under an interim CEO and interim executive chairman following the sudden removal of former ...

And finally, Abbott Laboratories' dividend record is an excellent reason to invest in the company. Abbott is a Dividend King, ...

When saving for retirement, the first decision is how much. But the next decision is where: Do you contribute to a ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this involves a beaten-down biotech stock that Wood has been buying regularly ...

Bristol Myers Squibb has struggled over the past few years due to patent cliffs. And to make matters worse, it will soon face even more, including for two of its best-selling medicines, cancer drug ...

If you're looking to boost your passive income, AGNC Investment is one appealing option. But there is one risk you should be ...

Among the 70 stocks (more or less) that I follow, many trade at very expensive valuations. Palantir is a good example. While ...